B · Normal
On October 19th, biotechnology company Antheia received an $80 million conditional financing commitment from the Office of Strategic Capital of the U.S. Department of War.
Related telegraphs
On October 14th, the stock price of Liquidia, an American biopharmaceutical comp
10-14 21:33
On October 10, the U.S. Food and Drug Administration (FDA) approved a drug for t
10-10 00:50
[Novartis Rhapsido® (remibrutinib) is approved by the FDA and becomes the first
10-07 23:53
[The Hang Seng Index and Hang Seng Technology Index both rose by about 1%, and p
10-06 16:09
On October 3, biopharmaceutical company Agenus reported that its BOT+BAL combina
10-03 22:54
[Preparations for the 2026 APEC Business Leaders Summit are progressing smoothly
09-29 11:24
Comments